Cargando…

ACT001 inhibits the proliferation of non‐small cell lung cancer cells by upregulating NKTR expression

BACKGROUND: Lung cancer, the primary cause of cancer‐related deaths worldwide, is diagnosed at an advanced stage and has a poor prognosis. Non‐small cell lung cancer (NSCLC) is a major histological type of lung malignancy. This study investigated the effect of ACT001, a novel sesquiterpene lactone d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Min, Qin, Tingting, Huang, Dingzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200889/ https://www.ncbi.nlm.nih.gov/pubmed/35537816 http://dx.doi.org/10.1111/1759-7714.14453

Ejemplares similares

circFOXM1 promotes proliferation of non-small cell lung carcinoma cells by acting as a ceRNA to upregulate FAM83D
por: Yu, Chengtao, et al.
Publicado: (2020)

Selective expansion of regulatory T cells by NKTR-358 in healthy volunteers and patients with systemic lupus erythematosus
por: Fanton, Christie, et al.
Publicado: (2022)

Nonclinical pharmacokinetics and activity of etirinotecan pegol (NKTR-102), a long-acting topoisomerase 1 inhibitor, in multiple cancer models
por: Hoch, Ute, et al.
Publicado: (2014)

POLR1B is upregulated and promotes cell proliferation in non-small cell lung cancer
por: Yang, Fan, et al.
Publicado: (2020)

YRDC is upregulated in non-small cell lung cancer and promotes cell proliferation by decreasing cell apoptosis
por: Shen, Haibo, et al.
Publicado: (2020)

Knockdown of Upregulated Gene 11 (URG11) Inhibits Proliferation, Invasion, and β-Catenin Expression in Non-Small Cell Lung Cancer Cells
por: Liu, Zhe-liang, et al.
Publicado: (2016)

Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
por: Sudo, Makoto, et al.
Publicado: (2013)

Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia
por: Luyt, Charles-Edouard, et al.
Publicado: (2009)

NKTR-061 (inhaled amikacin) delivers high lung doses in mechanically ventilated patients with pneumonia and in healthy subjects
por: Eldon, M, et al.
Publicado: (2008)

Bevacizumab/PD-1 inhibitor plus chemotherapy as first-line treatment of advanced non-squamous non-small-cell lung cancer
por: Wang, Jing, et al.
Publicado: (2023)

Epididymal protein 3A is upregulated and promotes cell proliferation in non-small cell lung cancer
por: Li, Guangbin, et al.
Publicado: (2020)

Gene expression profile of human colorectal cancer identified NKTR as a biomarker for liver metastasis
por: Bai, Rui, et al.
Publicado: (2022)

Upregulation of MiR-1280 Expression in Non-small Cell Lung Cancer Tissues
por: Xu, Li-Min, et al.
Publicado: (2015)

Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with Oxycodone
por: Webster, Lynn, et al.
Publicado: (2018)

High epithelial lining fluid concentrations of NKTR-061 (inhaled amikacin) twice daily achieved in pneumonic portions of lung
por: Chastre, J, et al.
Publicado: (2008)

Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer
por: Li, Yunxia, et al.
Publicado: (2018)

Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15
por: Fernandez, Rafael Alonso, et al.
Publicado: (2022)

NUCKS1 Promotes Proliferation, Invasion and Migration of Non-Small Cell Lung Cancer by Upregulating CDK1 Expression
por: Zhao, Shufen, et al.
Publicado: (2020)

Evaluation of the radiosensitizing effect of MEK inhibitor KZ-001 on non-small cell lung cancer cells in vitro
por: Huang, Gongchao, et al.
Publicado: (2023)

NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer
por: Adkins, Chris E., et al.
Publicado: (2015)

NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy
por: Miyazaki, Takahiro, et al.
Publicado: (2021)

TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins
por: Zhan, Weihua, et al.
Publicado: (2015)

Cx31.1 acts as a tumour suppressor in non-small cell lung cancer (NSCLC) cell lines through inhibition of cell proliferation and metastasis
por: Zhang, Deqiang, et al.
Publicado: (2012)

HER2 induces cell proliferation and invasion of non-small-cell lung cancer by upregulating COX-2 expression via MEK/ERK signaling pathway
por: Chi, Feng, et al.
Publicado: (2016)

NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8(+) T cell responses capable of curing multi-focal cancer
por: Walker, Joshua M, et al.
Publicado: (2020)

Long non-coding RNA LINRIS is upregulated in non-small cell lung cancer and its silencing inhibits cell proliferation by suppressing microRNA-10a maturation
por: Zhu, Yajie, et al.
Publicado: (2022)

Botrychium schaffneri Underw. extract acts via DIABLO to induce apoptosis and inhibit proliferation of non-small cell lung carcinoma in vitro and in vivo
por: Liu, Yu-Jia, et al.
Publicado: (2021)

Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer
por: Wang, Xinyue, et al.
Publicado: (2019)

Knockdown of PFTK1 Expression by RNAi Inhibits the Proliferation and Invasion of Human Non-Small Lung Adenocarcinoma Cells
por: Liu, Mei-han, et al.
Publicado: (2016)

NKTR-358: A novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseases
por: Dixit, Neha, et al.
Publicado: (2021)

Anticancer mechanism of breviscapine in non-small cell lung cancer A549 cells acts via ROS-mediated upregulation of IGFBP4
por: Wei, Weitian, et al.
Publicado: (2021)

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial
por: Subbiah, Vivek, et al.
Publicado: (2021)

ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
por: Tong, Luqing, et al.
Publicado: (2020)

The Study on Newly Developed McAb NJ001 Specific to Non-Small Cell Lung Cancer and Its Biological Characteristics
por: Pan, Shiyang, et al.
Publicado: (2012)

BATF acts as an oncogene in non-small cell lung cancer
por: Feng, Yu, et al.
Publicado: (2020)

miR-135a Confers Resistance to Gefitinib in Non-Small Cell Lung Cancer Cells by Upregulation of RAC1
por: Zhang, Tingting, et al.
Publicado: (2018)

MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer
por: Jing, Chuanqing, et al.
Publicado: (2021)

Inhibition of TRPC6 reduces non-small cell lung cancer cell proliferation and invasion
por: Yang, Li-Li, et al.
Publicado: (2016)

Silencing of PRDX2 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells
por: Jing, Xu, et al.
Publicado: (2020)

Silencing TRIM37 inhibits the proliferation and migration of non-small cell lung cancer cells
por: Ding, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dmh7mqj269b8degue8fs7chqjr